Critical Care Reviews Podcast

Rob Mac Sweeney discusses the ANDROMEDA-SHOCK 2 trial with Prof Jan Bakker, one of the leads for this major international randomised controlled trial investigating peripheral perfusion guided resuscitation in septic shock

Rob Mac Sweeney discusses the Tigris Trial with chief investigator John Kellum. Tigris investigated the efficacy of polymyxin B haemoadsorption in endotoxic septic shock. It was published in Lancet Respiratory Medicine in March, 2026.

Rob Mac Sweeney discusses the ACIOS study with Tim Baker, the study lead. ACIOS is a point prevalence study describing the burden of critical illness in Africa. It was published in the Lancet in March, 2025.

Rob Mac Sweeney discusses the IVIO trial with investigators Lars Wiuff Andersen and Mikael Fink Valentine from Aarhus, Denmark. The IVIO trial compared intraosseous with intravenous vascular access in adult patients suffering an out-of-hospital cardiac arrest. It was presented at the 2024 European Resuscitation Council congress in Athens and simultaneously published in the New England Journal of Medicine.

Rob Mac Sweeney discusses the PARAMEDIC 3 trial with it's investigators Keith Couple and Ranjit Lall from the University of Warwick, England. PARAMEDIC 3 compared intravenous with intraosseous vascular access in adult patients suffering cardiac arrest and requiring drug administration during ongoing resuscitation. It was presented at the European Resuscitation Council meeting in Athens on October 31st and simultaneously published in the New England Journal of Medicine.